Your browser doesn't support javascript.
loading
Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors.
Wu, Mei-Zhen; Teng, Tiew-Hwa Katherine; Tsang, Christopher Tze-Wei; Chan, Yap-Hang; Lee, Chi-Ho; Ren, Qing-Wen; Huang, Jia-Yi; Cheang, Iok-Fai; Tse, Yi-Kei; Li, Xin-Li; Xu, Xin; Tse, Hung-Fat; Lam, Carolyn S P; Yiu, Kai-Hang.
Afiliación
  • Wu MZ; Division of Cardiology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518000, China.
  • Teng TK; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Tsang CT; National Heart Centre Singapore, National Heart Research Institute of Singapore, Singapore, 169609, Singapore.
  • Chan YH; Duke-NUS Medical School, Cardiovascular Sciences Academic Clinical Programme, Singapore, 169857, Singapore.
  • Lee CH; School of Allied Health, University of Western Australia, Perth, 6009, Australia.
  • Ren QW; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Huang JY; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Cheang IF; Division of Endocrinology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Tse YK; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Li XL; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Xu X; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China.
  • Tse HF; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
  • Lam CSP; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China.
  • Yiu KH; Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 999077, China.
Eur Heart J Cardiovasc Pharmacother ; 10(1): 45-52, 2024 Jan 05.
Article en En | MEDLINE | ID: mdl-37942588
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hiperpotasemia / Hipopotasemia Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hiperpotasemia / Hipopotasemia Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2024 Tipo del documento: Article País de afiliación: China